Imaging diagnosis of early HCC still remains some troubles, and serum AFP has a non-negligible false negative rate of about 30%, which could potentially lead to misdiagnosis, missed diagnosis, and a delay in timely treatment (20–22). This evidence concerns the gene AFP and hepatocellular carcinoma.